Publication date: 10 February 2016
Source:Vaccine, Volume 34, Issue 7
Author(s): Debra D. Kristensen, Tina Lorenson, Kate Bartholomew, Shirley Villadiego
IntroductionThis study captures the perspectives of stakeholders at multiple levels of the vaccine supply chain regarding their assessment of challenges with storing vaccines within recommended temperature ranges and their perceptions on the benefits of having vaccines with improved stability, including the potential short-term storage and transport of vaccines in a controlled-temperature chain.MethodsSemi-structured interviews were undertaken with 158 immunization stakeholders in six countries. Interviewees included national decision-makers and advisors involved in vaccine purchasing decisions, national Expanded Programme on Immunization managers, and health and logistics personnel at national, subnational, and health facility levels.ResultsChallenges with both heat and freeze-exposure of vaccines were recognized in all countries, with heat-exposure being a greater concern. Conditions leading to freeze-exposure including ice build-up due to poor refrigerator performance and improper icepack conditioning were reported by 53% and 28% of participants, respectively. Respondents were interested in vaccine products with improved heat/freeze-stability characteristics. The majority of those involved in vaccine purchasing indicated they would be willing to pay a US$0.05 premium per dose for a freeze-stable pentavalent vaccine (68%) or a heat-stable rotavirus vaccine (59%), although most (53%) preferred not to pay the premium for a heat-stable pentavalent vaccine if the increased stability required changing from a liquid to a lyophilized product. Most respondents (73%) were also interested in vaccines labeled for short-term use in a controlled-temperature chain. The majority (115/158) recognized the flexibility this would provide during outreach or should cold-chain breaks occur. Respondents were also aware that possible confusion might arise and additional training would be required if handling conditions were changed for some, but not all vaccines.ConclusionParticipating immunization stakeholders recognized the benefits of vaccine products with improved stability characteristics and of labeling vaccines for controlled-temperature chain use as a means to help address cold-chain issues in their immunization programs.
from #Medicine via ola Kala on Inoreader http://ift.tt/206aBpl
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
-
▼
Φεβρουαρίου
(793)
-
▼
Φεβ 02
(50)
- A needs assessment of people living with diabetes ...
- Research participation after terrorism: an open co...
- Quantification of low molecular weight selenium me...
- GC-induced tethered repression need GR SUMOylation...
- GC-induced direct repression needs GR SUMOylation ...
- Detection of patterns in sound sequences [Neurosci...
- Spectral structure of intrinsic networks [Neurosci...
- A slow growth bacterial transcription factor [Micr...
- Subunit arrangement in a GluClR [Physiology]
- Correction for Sohl et al., Probing the structural...
- Correction to Supporting Information for Rosenzwei...
- Correction for Ling et al., Extremely high genetic...
- Correction for Ogasawara et al., Rapid and profoun...
- Social regulation of gene expression in zebrafish ...
- Latent EBV sensing via exosomal small RNA transfer...
- T-cell-intrinsic Tif1{alpha}/Trim24 regulates alle...
- MINCR is a MYC-induced lncRNA [Biological Sciences]
- TCF7L1 in HP axis development [Developmental Biology]
- Structure of NDP-forming Ac-CoA synthetase [Bioche...
- Seafood Consumption, Mercury, and Brain Neuropatho...
- National Cluster-Randomized Trial of Duty-Hour Fle...
- Establishment of Genome-edited Human Pluripotent S...
- Stem cell-like Xenopus Embryonic Explants to Study...
- Successful diagnosis of intrahepatic splenosis mim...
- Toward Optimum Benefit-Risk and Reduced Access Lag...
- Distribution patterns of stone-tool reduction: Est...
- La duplication rectale de l’adulte : une cause exc...
- Place de la coloscopie dans la prévention et le dé...
- Facteurs de risque d’hémorragies digestives par ru...
- Dual-Frequency Alternating Current Designer Wavefo...
- Detection of Borrelia burgdorferi sensu lato and s...
- Identification and characterization of Theileria o...
- An updated distribution and hosts: trombiculid mit...
- Antenatal immunisation intentions of expectant par...
- Editorial Board/Aims and Scope
- Clinical experience with the meningococcal B vacci...
- Impact of a publicly funded monovalent rotavirus v...
- Can thermostable vaccines help address cold-chain ...
- A trivalent vaccine candidate against hepatitis E ...
- Intradermal vaccination with un-adjuvanted sub-uni...
- Adverse events following immunization in patients ...
- Infant vaccination timing: Beyond traditional cove...
- Evaluation of the non-toxic mutant of the diphther...
- Immunogenicity and efficacy of alphavirus-derived ...
- The Use of Aspiration Catheter Systems for Embolic...
- Recombinant Brain Natriuretic Peptide for the Prev...
- Development of a Murine Infection Model with Leish...
- The Synthesis and Evaluations of the 68Ga-Lissamin...
- Evaluation of Hepatotoxicity with Treatment Doses ...
- Clinical Effect and Mechanism of Yisui Shengxue Gr...
-
▼
Φεβ 02
(50)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.